Henry Ford Health
Dr. Ramandeep Rattan is a Gynecologic Oncology Research Professor at Henry Ford Health. The Rattan lab is interested in better understanding and controlling abnormal ovarian cancer metabolism and immunometabolism. Macronutrient modification and metabolic inhibitors are two translational strategies used in the lab to improve the anti-tumor immune response and boost chemotherapy effects.
Dr. Rattan earned her doctorate from the Medical University of South Carolina and completed a postdoctoral fellowship at Mayo Clinic before joining Henry Ford Health to establish and head their ovarian cancer research program. She also holds joint appointments at Department of Oncology at Wayne State University School of Medicine and Department of Obstetrics, Gynecology and Reproductive Biology at the Michigan State University College of Human Medicine.
The Rivkin Center strives for excellence in our scientific programming. Our Scientific Advisory board guides the work we do and helps shape our vision for the future of ovarian cancer research. The Board is led by Dr. Mary L. (Nora) Disis, MD, our Scientific and Medical Director, and consists of nationally recognized experts in ovarian cancer research.